SGMO - SANGAMO THERAPEUTICS, INC

QQQ $ 590.73 $ 3.40 (0.58 %)

DIA $ 463.66 $ 4.22 (0.92 %)

SPY $ 659.72 $ 4.72 (0.72 %)

TLT $ 89.38 $ -0.28 (-0.31 %)

GLD $ 375.16 $ 1.17 (0.31 %)

Previous Close

$ 0.385

Open

$ 0.54

Bid

$ 0.42 x 100

Ask

$ 0.42 x 1,073

Day's Range

$ 0.40 - $ 0.56

52 Week Range

$ 0.38 - $ 2.84

Volume

4,679,309

Average Volume

Market Cap

129.55M

Beta (5Y Monthly)

$ 1.24

PE Ratio (TTM)

EPS (TTM)

TBD

Earnings Date

Dividend & Yield

na ($ 0.00)

Last Ex-Dividend

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type
1	11-06-2025	09-30-2025	10-Q
2	08-07-2025	06-30-2025	10-Q
3	05-12-2025	03-31-2025	10-Q
4	03-17-2025	12-31-2024	10-K
5	11-12-2024	09-30-2024	10-Q
6	08-06-2024	06-30-2024	10-Q
7	05-09-2024	03-31-2024	10-Q
8	03-13-2024	12-31-2023	10-K
9	11-01-2023	09-30-2023	10-Q
10	08-08-2023	06-30-2023	10-Q
11	05-08-2023	03-31-2023	10-Q
12	02-23-2023	12-31-2022	10-K
13	11-03-2022	09-30-2022	10-Q
14	08-04-2022	06-30-2022	10-Q
15	05-05-2022	03-31-2022	10-Q
16	02-24-2022	12-31-2021	10-K
17	11-04-2021	09-30-2021	10-Q
18	08-05-2021	06-30-2021	10-Q
19	05-04-2021	03-31-2021	10-Q
20	02-24-2021	12-31-2020	10-K
21	11-04-2020	09-30-2020	10-Q
22	08-05-2020	06-30-2020	10-Q
23	05-11-2020	03-31-2020	10-Q
24	02-28-2020	12-31-2019	10-K
25	11-06-2019	09-30-2019	10-Q
26	08-07-2019	06-30-2019	10-Q
27	05-08-2019	03-31-2019	10-Q
28	03-01-2019	12-31-2018	10-K
29	11-08-2018	09-30-2018	10-Q
30	08-08-2018	06-30-2018	10-Q
31	05-10-2018	03-31-2018	10-Q
32	03-01-2018	12-31-2017	10-K
33	11-09-2017	09-30-2017	10-Q
34	08-09-2017	06-30-2017	10-Q
35	05-10-2017	03-31-2017	10-Q
36	02-28-2017	12-31-2016	10-K
37	10-27-2016	09-30-2016	10-Q
38	08-04-2016	06-30-2016	10-Q
39	05-05-2016	03-31-2016	10-Q
40	02-18-2016	12-31-2015	10-K

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

12-health-care-stocks-moving-in-fridays-intraday-session

12 Health Care Stocks Moving In Friday's I...
11/21/2025 17:05:46

Sangamo Therapeutics Biologics License App...
11/21/2025 13:08:13

Sangamo Therapeutics, Inc. (NASDAQ:SGMO), a genomic medicine company, today announced that the U.S. Food and Drug Administratio...

12 Health Care Stocks Moving In Monday's A...
11/10/2025 21:07:39

this-carmax-analyst-is-no-longer-bullish-here-are-top-5-downgrades-for-friday

This CarMax Analyst Is No Longer Bullish; ...
11/07/2025 13:53:44

Barclays Downgrades Sangamo Therapeutics t...
11/07/2025 12:24:35

Barclays analyst Gena Wang downgrades Sangamo Therapeutics (NASDAQ:SGMO) from Overweight to Equal-Weight and lowers the pric...

Sangamo Therapeutics Q3 EPS $(0.11) Misses...
11/06/2025 13:02:18

Sangamo Therapeutics (NASDAQ:SGMO) reported quarterly losses of $(0.11) per share which missed the analyst consensus estimate o...

Earnings Scheduled For November 6, 2025
11/06/2025 11:12:19

On September 9, Sangamo Therapeutics CFO P...
09/11/2025 21:08:32

-SEC Filing

HC Wainwright & Co. Reiterates Buy on Sang...
09/04/2025 16:12:59

HC Wainwright & Co. analyst Patrick R. Trucchio reiterates Sangamo Therapeutics (NASDAQ:SGMO) with a Buy and maintains $...

Sangamo Therapeutics Q2 EPS $(0.08) Misses...
08/07/2025 20:08:37

Sangamo Therapeutics (NASDAQ:SGMO) reported quarterly losses of $(0.08) per share which missed the analyst consensus estimate o...

Earnings Scheduled For August 7, 2025
08/07/2025 08:33:15

'South Africa, Gates Foundation Pledge Fun...
08/04/2025 16:40:22

https://www.bloomberg.com/news/articles/2025-08-04/south-africa-gates-step-in-after-us-defunds-hiv-research

HC Wainwright & Co. Reiterates Buy on Sang...
06/24/2025 16:40:14

HC Wainwright & Co. analyst Patrick Trucchio reiterates Sangamo Therapeutics (NASDAQ:SGMO) with a Buy and maintains $10 ...

Sangamo Therapeutics Announces Topline Res...
06/24/2025 12:10:25

STAAR study demonstrated positive mean annualized estimated glomerular filtration rate (eGFR) slope at 52-weeks across all dose...

Barclays Maintains Overweight on Sangamo T...
05/14/2025 15:07:44

Barclays analyst Gena Wang maintains Sangamo Therapeutics (NASDAQ:SGMO) with a Overweight and lowers the price target from $...

12 Health Care Stocks Moving In Tuesday's ...
05/13/2025 17:06:46

12 Health Care Stocks Moving In Tuesday's ...
05/13/2025 12:10:18

us-stocks-likely-to-open-lower-after-a-strong-rally-lows-are-likely-in-and-better-times-are-coming-says-expert

US Stocks Likely To Open Lower After A Str...
05/13/2025 09:45:38

U.S. stock futures fell on Tuesday after a stellar rally on Monday. Futures of major benchmark indices were trading lower in pr...

why-coinbase-global-shares-are-trading-higher-by-over-9-here-are-20-stocks-moving-premarket

Why Coinbase Global Shares Are Trading Hig...
05/13/2025 09:28:26

Sangamo Therapeutics Q1 EPS $(0.14) Misses...
05/12/2025 22:38:35

Sangamo Therapeutics (NASDAQ:SGMO) reported quarterly losses of $(0.14) per share which missed the analyst consensus estimate o...